Brazil

 

Rede D’Or bids for Alliar

Brazil's largest hospital group Rede D'Or has launched a takeover bid for one of the country's largest diagnostic groups Alliar. 
August 16, 2021

Rede D’Or to build new hospitals with $340m follow-on

Brazil's largest hospital group Rede D'Or has raised $340m in new shares with a follow-on that includes Carlyle selling down its stake. It says it will use the proceeds of the primary offering to build and acquire new assets.
May 27, 2021

Fleury acquires Sao Paulo orthopaedics group

Fleury Group, the second largest diagnostics group in Brazil, has signed an agreement to buy a two-thirds stake in orthopaedic and rehabilitation specialist Vita Ortopedia Servicos Especializados. This continues its march towards becoming an integrated platform.
April 15, 2021

$20bn merger could transform Brazilian healthcare market

A $20bn merger between two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Notre Dame Intermedica Participacoes SA (GNDI), will create one of the world’s biggest companies providing verticalized health-care solutions. HBI looks at the deal in detail, and talks to a Brazil-based operator to find out more.
March 4, 2021

Atrys CFO on recent M&A and pan-European radiotherapy plans

Spain-listed diagnostics and radiotherapy group Atrys Health's CFO talks HBI through the strategic rationale of its spate of recent acquisitions including a €550m merger with another listed group, after we questioned the diversity of deal-making it is pursuing. He says it is looking at acquiring radiotherapy centres in Europe outside Iberia. 
February 17, 2021

Rede d’Or’s payors losing market cap

Analysts covering Brazil's largest private hospital Rede d'Or have projected a 25% rise share price after its $2.2bn IPO last month. However, the sustainability of its fee-for-service business model in the long-term has been questioned by some. Its insurers are slowly losing market cap to integrated players.
January 21, 2021

UHCG faces tough call in Brazil

Amy Shaw, the incoming CEO of UnitedHealthcare Global (UHCG), the world's largest owner of for-profit hospitals in emerging markets, faces tough choices. UHCG, the international arm of US insurer UnitedHealth, has a colossal headache in Brazil, by far its largest market. For instance, reports suggest UHCG may have to pay R$1bn to shift its personal policy portfolio in a deal which has already been sweetened by the addition of several hospitals. There is speculation that, like Cigna in the 1990s, which wrote off some US$500m on medical plan Golden Cross, that UnitedHealth may decide to exit Brazil completely. A full pull-out looks unlikely, but the full year 2020 results to be announced on Wednesday, January 20 may well see big write-offs. 
January 15, 2021

HBI 2020: Hospital sector is moving to outcome-based payment – insurers may get left behind

The for-profit hospital sector is moving slowly but inexorably towards value and outcome-linked reimbursement and the role for insurers within that, if there is one, is far from clear. That was the message from HBI 2020's 'Hospitals: The balance of power with payors' session where the CEOs of Mediclinic International and Steward Health Care discussed the topic with an ex-UnitedHealth Group executive.
December 17, 2020
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us